GB0015496D0 - Antitumour and anti-angiogenic compound - Google Patents

Antitumour and anti-angiogenic compound

Info

Publication number
GB0015496D0
GB0015496D0 GB0015496A GB0015496A GB0015496D0 GB 0015496 D0 GB0015496 D0 GB 0015496D0 GB 0015496 A GB0015496 A GB 0015496A GB 0015496 A GB0015496 A GB 0015496A GB 0015496 D0 GB0015496 D0 GB 0015496D0
Authority
GB
United Kingdom
Prior art keywords
antitumour
angiogenic compound
angiogenic
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0015496A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmamar SA
Original Assignee
Pharmamar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmamar SA filed Critical Pharmamar SA
Priority to GB0015496A priority Critical patent/GB0015496D0/en
Publication of GB0015496D0 publication Critical patent/GB0015496D0/en
Priority to ES00976137T priority patent/ES2288486T3/en
Priority to MXPA02004862A priority patent/MXPA02004862A/en
Priority to SI200030960T priority patent/SI1229922T1/en
Priority to HU0203906A priority patent/HUP0203906A2/en
Priority to AU14023/01A priority patent/AU780417B2/en
Priority to CZ20021697A priority patent/CZ302498B6/en
Priority to DK00976137T priority patent/DK1229922T3/en
Priority to RU2002115864/14A priority patent/RU2261104C2/en
Priority to CA002391502A priority patent/CA2391502A1/en
Priority to PL355335A priority patent/PL200922B1/en
Priority to DE60035120T priority patent/DE60035120T2/en
Priority to KR10-2002-7006155A priority patent/KR100518986B1/en
Priority to JP2001537965A priority patent/JP2003514025A/en
Priority to CN00818404A priority patent/CN1423564A/en
Priority to UA2002064929A priority patent/UA78186C2/en
Priority to AT00976137T priority patent/ATE363910T1/en
Priority to PCT/GB2000/004349 priority patent/WO2001035974A2/en
Priority to SK659-2002A priority patent/SK287762B6/en
Priority to EP00976137A priority patent/EP1229922B1/en
Priority to BR0015811-9A priority patent/BR0015811A/en
Priority to NZ518847A priority patent/NZ518847A/en
Priority to PT00976137T priority patent/PT1229922E/en
Priority to IL14948800A priority patent/IL149488A0/en
Priority to NO20022293A priority patent/NO330719B1/en
Priority to BG106714A priority patent/BG65381B1/en
Priority to HK02106981.6A priority patent/HK1045648B/en
Priority to CY20071101110T priority patent/CY1106825T1/en
Priority to US12/342,478 priority patent/US20090298752A1/en
Ceased legal-status Critical Current

Links

GB0015496A 1999-11-15 2000-06-23 Antitumour and anti-angiogenic compound Ceased GB0015496D0 (en)

Priority Applications (29)

Application Number Priority Date Filing Date Title
GB0015496A GB0015496D0 (en) 2000-06-23 2000-06-23 Antitumour and anti-angiogenic compound
IL14948800A IL149488A0 (en) 1999-11-15 2000-11-15 Pharmaceutical compositions containing aplidine
CN00818404A CN1423564A (en) 1999-11-15 2000-11-15 APLIDINE treatment of cancers
AT00976137T ATE363910T1 (en) 1999-11-15 2000-11-15 TREATMENT OF CANCER DISEASES BY APLIDINE
UA2002064929A UA78186C2 (en) 2000-06-23 2000-11-15 Use of aplidine for treatment of malignant tumours
HU0203906A HUP0203906A2 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
MXPA02004862A MXPA02004862A (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers.
CZ20021697A CZ302498B6 (en) 1999-11-15 2000-11-15 Pharmaceutical composition containing aplidine for treating cancer diseases
DK00976137T DK1229922T3 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
RU2002115864/14A RU2261104C2 (en) 1999-11-15 2000-11-15 Treatment of malignant tumor with aplidine
CA002391502A CA2391502A1 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
PL355335A PL200922B1 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
DE60035120T DE60035120T2 (en) 1999-11-15 2000-11-15 TREATMENT OF CANCER DISORDERS BY APLIDINE
PCT/GB2000/004349 WO2001035974A2 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
JP2001537965A JP2003514025A (en) 1999-11-15 2000-11-15 Aplidine treatment for cancer
ES00976137T ES2288486T3 (en) 1999-11-15 2000-11-15 TREATMENT OF CANCERES WITH APLIDINA.
SI200030960T SI1229922T1 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
AU14023/01A AU780417B2 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
KR10-2002-7006155A KR100518986B1 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
SK659-2002A SK287762B6 (en) 1999-11-15 2000-11-15 Use of aplidine in preparation of pharmaceutical composition for treating cancer
EP00976137A EP1229922B1 (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
BR0015811-9A BR0015811A (en) 1999-11-15 2000-11-15 Treatment of cancers with aplidine
NZ518847A NZ518847A (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
PT00976137T PT1229922E (en) 1999-11-15 2000-11-15 Aplidine treatment of cancers
NO20022293A NO330719B1 (en) 1999-11-15 2002-05-14 Use of aplidine in the manufacture of a pharmaceutical composition for the treatment of cancer in a human patient
BG106714A BG65381B1 (en) 1999-11-15 2002-05-18 Use of aplidine in the preparation of a pharmaceutical composition for treatment of cancer
HK02106981.6A HK1045648B (en) 1999-11-15 2002-09-25 Aplidine treatment of cancers
CY20071101110T CY1106825T1 (en) 1999-11-15 2007-08-30 TREATMENT OF CANCER WITH APLIDINE
US12/342,478 US20090298752A1 (en) 1999-11-15 2008-12-23 Aplidine treatment of cancers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0015496A GB0015496D0 (en) 2000-06-23 2000-06-23 Antitumour and anti-angiogenic compound

Publications (1)

Publication Number Publication Date
GB0015496D0 true GB0015496D0 (en) 2000-08-16

Family

ID=9894324

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0015496A Ceased GB0015496D0 (en) 1999-11-15 2000-06-23 Antitumour and anti-angiogenic compound

Country Status (2)

Country Link
GB (1) GB0015496D0 (en)
UA (1) UA78186C2 (en)

Also Published As

Publication number Publication date
UA78186C2 (en) 2007-03-15

Similar Documents

Publication Publication Date Title
HRP20031000A2 (en) Benzoylsulfonamides and sulfonylbenzamidines as antitumour agents
IL154609A0 (en) Anti-angiogenic polypeptides
GB2372811B (en) Stain
HUP0201417A2 (en) Pallet
GB0015496D0 (en) Antitumour and anti-angiogenic compound
GB0007639D0 (en) Antitumour and anti-angiogenic compound
AU5496701A (en) Anti-angiogenic polypeptides
GB0019705D0 (en) Factor
GB2369445B (en) Component measures
CA89440S (en) Pallet
CA89552S (en) Pallet
CA89553S (en) Pallet
CA88521S (en) Pallet
GB0003629D0 (en) Antitumour agent
GB0006741D0 (en) Antitumour compound
GB0007637D0 (en) Antitumour compound
AU143949S (en) Pallet
GB0026878D0 (en) Pallet
TW441572U (en) Pallet
GB0007182D0 (en) Pallet
AU143858S (en) Pallet
AU143857S (en) Pallet
AU1893P (en) Novasnow Sutera cordata
AU141881S (en) Pallet angle
AU145426S (en) Pallet angle

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)